Much less is known about how the activity of insulin-producing cells and consequently the secretion of insulin is controlled.

People with a severe form of diabetes, where the beta cells of the pancreas do not produce or no longer produce enough insulin

One type of bacteria found in the gut may contribute to the development of Type 2 diabetes, while another may protect from the disease.

One reason that it’s so difficult to deliver large protein drugs orally is that these drugs can’t pass through the mucus barrier.

Mebourne researchers have answered a 100-year-old question in diabetes research: can a molecule different to insulin have the same effect?

Are we moving closer to the day when diabetes is no longer monitored and managed by blood sugar tests, insulin injections or drug treatments

Scientists has identified two distinct types of obesity with physiological and molecular differences that may have lifelong consequences.

People with a severe form of diabetes, where the beta cells of the pancreas do not produce or no longer produce enough insulin.

Are we moving closer to the day when diabetes is no longer monitored and managed with blood sugar tests, insulin or drug treatments.

A new drug capsule developed at MIT can help large proteins such as insulin and small-molecule drugs be absorbed in the digestive tract.

People with a severe form of diabetes, where the beta cells of the pancreas do not produce or no longer produce enough insulin.

Scientists has identified two types of obesity with physiological and molecular differences that may have lifelong consequences for health.

Researchers have developed an oral medication to treat diabetes that controls insulin levels while reversing its inflammatory effects.

One reason that it’s so difficult to deliver large protein drugs orally is that these drugs can’t pass through the mucus barrier.

People with a severe form of diabetes, where the beta cells of the pancreas do not produce or no longer produce enough insulin.

Scientists identified two distinct types of obesity with physiological and molecular differences that have lifelong consequences for health.

Yale researchers have developed an oral medication to treat diabetes that controls insulin levels while simultaneously reversing the disease

Implantable devices that release insulin into the body hold promise as an alternative way to treat diabetes without insulin injections.

Researchers have developed an oral medication to treat diabetes while simultaneously reversing the inflammatory effects of the disease.

A new oral medication treats diabetes and controls insulin levels while simultaneously reversing the inflammatory effects of the disease.